HSIC Stock — Henry Schein Inc.

Henry Schein Inc. (HSIC)

Updated October 16, 2026.

HSIC is a Stock. Total return is 1836.4% over the past 31 years, 264.1 points behind SPY at 2100.5%.

Henry Schein is a healthcare distributor and services company that supplies dental and medical practitioners with products ranging from infection-control supplies and equipment to pharmaceuticals and diagnostic tests, while also manufacturing specialty dental products and offering practice management software. The company operates through three segments: distribution and value-added services to dental and medical practices, specialty products manufacturing, and technology solutions for healthcare providers. Distribution frequency is not applicable as this is an operating company rather than an income-focused security.

HSIC performance versus SPY

Price and return data through 2026-10-16.

Total return is 1836.4% over the past 31 years, 264.1 points behind SPY at 2100.5%. Over the past year its total return — price change plus distributions reinvested — is 39.3%. Its deepest 1-year drawdown was 17.2%.

HSIC key facts

Asset type

Stock

Asset class

Equity

Inception date

11/03/1995

Distribution frequency

None

Last close

$86.38 (stale; as of 2026-10-16)

Market cap

$9,626,752,298

Average volume

1178800.0

Beta

0.812

Payout ratio

0.0%

P/E ratio

25.18

Forward P/E

14.8148

EPS

$3.43

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HSIC risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 17.2%.

Who may consider HSIC — and who may not

It is a weaker fit for investors who need monthly cash flow (HSIC does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on HSIC

• All tickers starting with H

Tagged: Healthcare.

Frequently asked questions